Status:
COMPLETED
Blood Glucose Control With A Software-Algorithm In Intensive Care Unit (ICU) Patients
Lead Sponsor:
B. Braun Melsungen AG
Conditions:
Critical Illness
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hyperglycemia is common in critically ill patients and associated with an adverse outcome. Recently, large randomized controlled trials have demonstrated that tight glycaemic control (TGC) reduces mor...
Eligibility Criteria
Inclusion
- Age: \> 18 years of age
- Stay in the ICU expected to be \> 120 h
- Blood glucose \> 110 mg/dl or patient on insulin treatment
Exclusion
- Patients with hyperglycaemic crisis/ketoacidosis due to insulin deficiency.
- Known or suspected allergy to insulin
- Any disease or condition which the investigator or treating physician feels would interfere with the trial or the safety of the patient (i.e., liver failure, other fatal organ failures)
- Moribund patients likely to die within 24 hours
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00735163
Start Date
September 1 2008
End Date
February 1 2009
Last Update
April 16 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University Graz
Graz, Austria, 8036